SCHEMBL445573

SCHEMBL445573

CCCCCCCC/C=C\CCCCCCCC(N)CCCCCCCCCCCCCCCC

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR2 O95136 5/20 0.55
S1PR1 P21453 5/20 0.55
S1PR3 Q99500 5/20 0.55
S1PR4 O95977 4/20 0.55
FAAH O00519 3/20 0.52
TRPV1 Q8NER1 1/20 0.52
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
TP53 P04637 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C19 P33261 2/20 0.50
PLA2G1B P04054 1/20 0.50
PLA2G2A P14555 1/20 0.50
CYP3A4 P08684 1/20 0.50
SOAT1 P35610 1/20 0.50
MAPT P10636 3/20 0.47
GMNN O75496 2/20 0.47
LMNA P02545 2/20 0.47
GLA P06280 2/20 0.47
POLB P06746 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10795834 1.00 S1PR2 (0.55) S1PR2S1PR1S1PR3S1PR4FAAH
SCHEMBL21752772 1.00 S1PR2 (0.55) S1PR2S1PR1S1PR3S1PR4FAAH
SCHEMBL5280575 1.00 S1PR2 (0.55) S1PR2S1PR1S1PR3S1PR4FAAH
SCHEMBL21199830 1.00 S1PR2 (0.55) S1PR2S1PR1S1PR3S1PR4FAAH
SCHEMBL21199828 1.00 S1PR2 (0.55) S1PR2S1PR1S1PR3S1PR4FAAH
SCHEMBL23390575 1.00 S1PR2 (0.55) S1PR2S1PR1S1PR3S1PR4FAAH
SCHEMBL21752776 1.00 S1PR2 (0.55) S1PR2S1PR1S1PR3S1PR4FAAH
SCHEMBL21199406 1.00 S1PR2 (0.55) S1PR2S1PR1S1PR3S1PR4FAAH
SCHEMBL21199407 1.00 S1PR2 (0.55) S1PR2S1PR1S1PR3S1PR4FAAH
SCHEMBL506443 1.00 S1PR2 (0.55) S1PR2S1PR1S1PR3S1PR4FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720218-A1 METHOD OF SYNTHESIS OF COLLOIDAL INSB QUANTUM DOTS Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) 2026-04-08 EP claimed
WO-2024246574-A1 METHOD OF SYNTHESIS OF COLLOIDAL InSb QUANTUM DOTS COMMISSARIAT À L'ENERGIE ATOMATIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2024-12-05 WO claimed
US-11731905-B2 Emulsifying composition for spreading bitumen ARKEMA FRANCE (FR) 2023-08-22 US claimed
EP-2566874-B1 SOLVENT-FREE ORGANOSILANE QUATERNARY AMMONIUM COMPOSITIONS, METHOD OF MAKING AND USE RESOURCE DEV LLC (US) 2023-01-18 EP claimed
US-20210403493-A1 USE OF TWO-TAIL LONG-CHAIN ANIONIC SURFACTANTS IN AQUEOUS POLYURETHANE DISPERSIONS EVONIK OPERATIONS GMBH (DE) 2021-12-30 US claimed
EP-3929352-A1 USE OF DIVALENT LONG-CHAIN ANIONIC SURFACTANTS IN AQUEOUS POLYURETHANE DISPERSIONS Evonik Operations GmbH (DE) 2021-12-29 EP claimed
EP-3612591-B1 APPLICATION EMULGATOR COMPOSITION FOR BITUMEN ARKEMA FRANCE (FR) 2021-06-09 EP claimed
EP-3612591-A1 EMULSIFYING COMPOSITION FOR SPREADING BITUMEN Arkema France (FR) 2020-02-26 EP claimed
US-20200039880-A1 EMULSIFYING COMPOSITION FOR SPREADING BITUMEN ARKEMA FRANCE (FR) 2020-02-06 US claimed
WO-2018193206-A1 EMULSIFYING COMPOSITION FOR SPREADING BITUMEN ARKEMA FRANCE (FR) 2018-10-25 WO claimed
EP-1567191-B1 NOVEL AMINE-BASED ADJUVANT EUROCINE VACCINES AB (SE) 2010-09-08 EP claimed
US-20080090742-A1 Compound and method of making the compound AFTON CHEMICAL CORPORATION 2008-04-17 US claimed
EP-3855182-B1 METHOD FOR OBTAINING INFORMATION ON COGNITIVE FUNCTION SYSMEX CORP (JP) 2026-04-29 EP disclosed
US-12595385-B2 Inkjet inks KAO CORPORATION (JP) 2026-04-07 US disclosed
EP-3809135-B1 METHOD AND REAGENT FOR MEASURING LIPOPROTEIN'S UPTAKE ABILITY SYSMEX CORP (JP) 2026-01-14 EP disclosed
US-12508582-B2 Tungsten-containing bulk catalysts, method of making the same, and their use in low pressure diesel hydroprocessing ExxonMobil Technology and Engineering Company (US) 2025-12-30 US disclosed
US-4512903-A Lubricant compositions containing amides of hydroxy-substituted aliphatic acids and fatty amines TEXACO INC. (US) 1985-04-23 US disclosed
US-4446038-A Citric imide acid compositions and lubricants containing the same TEXACO, INC. (US) 1984-05-01 US disclosed
US-4237022-A ANTI-CORROSION, ANTI-RUST AND FRICTION REDUCTION THE LUBRIZOL CORPORATION (US) 1980-12-02 US disclosed
US-4121898-A Process for dyeing synthetic polyamide fibre materials BAYER AKTIENGESELLSCHAFT (DE) 1978-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595385-B2 Inkjet inks EBP, ADRA1D, ADRA1A S1PR2 2779/4885S1PR1 2461/4885S1PR3 2620/4885
US-20210403493-A1 USE OF TWO-TAIL LONG-CHAIN ANIONIC SURFACTANTS IN AQUEOUS POLYURETHANE DISPERSIONS PUF60, PHOSPHO1, PIGS S1PR2 819/4885S1PR1 1926/4885S1PR3 1413/4885
US-12508582-B2 Tungsten-containing bulk catalysts, method of making the same, and their use in low pressure diesel hydroprocessing HAX1, AP2S1, AP3S1 S1PR2 2517/4885S1PR1 2500/4885S1PR3 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.